Cookies deactivated. To use all functions on this portal, for example the login, Cookies must be activated. Please activate Cookies in your browser settings.
UBS AM invests £66m in new life sciences facility for cancer therapies
UBS Asset Management (UBS-AM) Real Estate & Private Markets (REPM) is providing £66 million in forward funding for a state-of-the-art pharmaceutical facility, pre-let to Autolus Therapeutics on a 20-year lease, working with development partner Reef Estates.
Print